Akso Health Group (FRA:8HX)
1.260
-0.050 (-3.82%)
At close: Nov 28, 2025
Akso Health Group Cash Flow Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | -134.98 | -9.46 | -1.36 | -16.85 | -34.83 | Upgrade |
Depreciation & Amortization | 2.15 | - | - | - | - | Upgrade |
Asset Writedown & Restructuring Costs | 162.48 | - | - | - | - | Upgrade |
Stock-Based Compensation | - | - | - | 0.39 | 0.06 | Upgrade |
Provision & Write-off of Bad Debts | -0.1 | 7.37 | 8.27 | - | - | Upgrade |
Other Operating Activities | -31.39 | 0.74 | -11.72 | 12.75 | 27.37 | Upgrade |
Change in Accounts Receivable | -0.86 | 0.33 | -8.1 | - | - | Upgrade |
Change in Inventory | - | 1.5 | 6.11 | -7.8 | - | Upgrade |
Change in Accounts Payable | 0.42 | 0.17 | 0.71 | 0.15 | -0.04 | Upgrade |
Change in Unearned Revenue | 9.86 | 0.22 | 0.19 | - | - | Upgrade |
Change in Income Taxes | -0.04 | -0.02 | 0 | 0.09 | - | Upgrade |
Change in Other Net Operating Assets | -6.36 | -0.13 | -0.1 | -0.02 | -0.15 | Upgrade |
Operating Cash Flow | 1.18 | 1.35 | -3.25 | -8.63 | 10.06 | Upgrade |
Operating Cash Flow Growth | -12.88% | - | - | - | - | Upgrade |
Capital Expenditures | -0.15 | - | - | - | - | Upgrade |
Cash Acquisitions | -93.75 | -56.25 | - | - | - | Upgrade |
Other Investing Activities | - | - | - | 0.04 | -0 | Upgrade |
Investing Cash Flow | -105.91 | -54.72 | 18.47 | -19.96 | -0 | Upgrade |
Short-Term Debt Issued | - | - | - | 9.09 | 14.63 | Upgrade |
Total Debt Issued | - | - | - | 9.09 | 14.63 | Upgrade |
Short-Term Debt Repaid | - | -7.69 | -27.51 | - | - | Upgrade |
Long-Term Debt Repaid | - | - | - | -10 | -10 | Upgrade |
Total Debt Repaid | - | -7.69 | -27.51 | -10 | -10 | Upgrade |
Net Debt Issued (Repaid) | - | -7.69 | -27.51 | -0.91 | 4.63 | Upgrade |
Issuance of Common Stock | 195.88 | 139.34 | - | 10.02 | 0 | Upgrade |
Other Financing Activities | - | - | - | 25.68 | -13.67 | Upgrade |
Financing Cash Flow | 195.88 | 131.65 | -27.51 | 34.78 | -9.04 | Upgrade |
Foreign Exchange Rate Adjustments | -1.12 | -1.27 | -0.44 | 0.61 | 3.18 | Upgrade |
Net Cash Flow | 90.03 | 77.01 | -12.73 | 6.8 | 4.2 | Upgrade |
Free Cash Flow | 1.02 | 1.35 | -3.25 | -8.63 | 10.06 | Upgrade |
Free Cash Flow Growth | -24.31% | - | - | - | - | Upgrade |
Free Cash Flow Margin | 6.92% | 55.97% | -24.68% | -143.81% | - | Upgrade |
Free Cash Flow Per Share | 0.00 | 0.03 | -0.14 | -0.43 | 0.62 | Upgrade |
Cash Interest Paid | - | 0.11 | 0.34 | 0.68 | 2.11 | Upgrade |
Cash Income Tax Paid | 0 | 0.02 | 0.02 | 0.09 | - | Upgrade |
Levered Free Cash Flow | 46.67 | -50.05 | 11.54 | -19.15 | 19.68 | Upgrade |
Unlevered Free Cash Flow | 46.67 | -50.05 | 11.54 | -18.65 | 21.03 | Upgrade |
Change in Working Capital | 3.02 | 2.06 | -1.17 | -7.57 | -0.2 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.